HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer.

AbstractAIM OF THE STUDY:
To study high mobility group protein B1 (HMGB1) and nuclear transcription factor p65 (NF-κB p65) expression in non-small cell lung cancer and its significance.
MATERIAL AND METHODS:
106 hospitalized patients with non-small cell lung cancer after thoracic surgery were enrolled; HMGB1 and p65 protein expression was detected by the immunohistochemical method. Semiquantitative expression of HMGB1 and NF-κB p65 was analyzed using Image Pro Plus (IPP) software and statistical analysis.
RESULTS:
The rate of HMGB1 positive expression in the non-small cell lung cancer protein B1 family was significantly higher than normal tissues (P < 0.05); p65 protein expression in the non-small cell lung carcinoma group was significantly higher than that of normal tissues (P < 0.05). HMGB1 and NF-κB p65 protein expression was significantly higher compared with the non-metastatic group (P < 0.01). HMGB1 and NF-κB p65 protein expression showed a positive correlation (P < 0.05).
CONCLUSIONS:
HMGB1 and NF-κB p65 expression may be related to non-small cell lung cancer metastasis.
AuthorsXiaohong Zhang, Hongmin Wang, Jing Wang
JournalContemporary oncology (Poznan, Poland) (Contemp Oncol (Pozn)) Vol. 17 Issue 4 Pg. 350-5 ( 2013) ISSN: 1428-2526 [Print] Poland
PMID24592122 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: